Alzheimer’s Therapeutics Market Size to Surpass USD 7.8 billion by 2032
In 2022, the global size for Alzheimer's therapeutics market reached USD 5.2 billion, and it is anticipated to achieve a value of USD 7.8 billion by 2032, with a compound annual growth rate (CAGR) of 4.2% throughout the forecast period. The primary driver behind this revenue surge is the escalating incidence of Alzheimer's disease, attributed to aging populations and changes in lifestyle.
